Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.

Flinn, Ian W; Gribben, John G; Dyer, Martin J S; Wierda, William; Maris, Michael B; Furman, Richard R; Hillmen, Peter; Rogers, Kerry A; Iyer, Swaminathan Padmanabhan; Quillet-Mary, Anne; Ysebaert, Loic; Walter, Harriet S; Verdugo, Maria; Klein, Christian; Huang, Huang; Jiang, Yanwen; Lozanski, Gerard; Pignataro, Daniela Soriano; Humphrey, Kathryn; Mobasher, Mehrdad; Kipps, Thomas J.
Blood; 133(26): 2765-2775, 2019 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-30862645

Não foram localizados documentos relacionados